000 01106 a2200313 4500
005 20250516234730.0
264 0 _c20150616
008 201506s 0 0 eng d
022 _a1557-7422
024 7 _a10.1089/hum.2014.090
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchagen, Frederik H E
245 0 0 _aOff-label prescription of genetically modified organism medicines in europe: emerging conflicts of interest?
_h[electronic resource]
260 _bHuman gene therapy
_cOct 2014
300 _a893-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aEurope
650 0 4 _aGenetic Therapy
650 0 4 _aHumans
650 0 4 _aLegislation, Drug
650 0 4 _aNetherlands
650 0 4 _aOff-Label Use
_xlegislation & jurisprudence
650 0 4 _aOrganisms, Genetically Modified
650 0 4 _aPharmaceutical Preparations
_xstandards
700 1 _aHoeben, Rob C
700 1 _aHospers, Geke A P
773 0 _tHuman gene therapy
_gvol. 25
_gno. 10
_gp. 893-6
856 4 0 _uhttps://doi.org/10.1089/hum.2014.090
_zAvailable from publisher's website
999 _c24234300
_d24234300